Abstract-Trypanothione reductase (TryR) is a well-established target in the search for novel antitrypanosomal and antileishmanial agents. We have previously identified linear and lactambridged 13-residue peptides derived from an -helical region making up part of the dimeric interface of Leishmania infantum TryR (Li-TryR) which prevent trypanothione reduction by disrupting enzyme dimerization. We now show that i,i+4 side-chain cross-linking with an allhydrocarbon staple stabilizes the helical structure of these peptides and significantly improves their resistance to protease cleavage relative to previous linear and cyclic lactam analogues.
Introduction
Leishmania parasites are the causative agents of leishmaniasis, a neglected tropical disease that is still endemic in more than 80 countries worldwide, according to the World Health Organization. The most lethal form of the disease is visceral leishmaniasis (VL), also known as kala-azar, predominantly caused by Leishmania donovani and Leishmania infantum species which is invariably fatal if left untreated [1] . Because resistance to current therapeutic options, which involve long and costly treatments, is commonplace and the medicines used are considerably toxic [2] [3] [4] , there is a pressing need for innovative drugs that act on new molecular targets and/or employ novel mechanisms of action.
A frequently exploited strategy to develop potent and specific antileishmanial drugs is to try and disrupt a metabolic pathway that is vital for the parasite and has no direct counterpart in the host. Trypanothione reductase (TryR), due to its key role in the maintenance of cellular redox homeostasis in Leishmania and other trypanosomatids, is an essential enzyme for survival of these parasites [5, 6] . The Try/TryR system is analogous to the mammalian glutathione/glutathione reductase (GSH/GR) pair involved in redox status regulation. However, the significant differences in the active site architectures of the enzymes from parasites and human beings facilitate the development of inhibitors selective for TryR over H-GR. TryR is a well-established drug target for antiparasitic drug design, with almost all known inhibitors targeting its active site [7] [8] [9] . This enzyme belongs to the large and well-characterized family of FAD-dependent NADPH oxidoreductases. From a structural viewpoint, TryR is a homodimer containing distinct domains for FAD-binding, NADPH-binding and interfacial recognition.
We recently explored an alternative approach for TryR inhibition that consists of disrupting protein-protein interactions (PPIs) at the homodimer interface [10] . Computational and experimental site-directed mutagenesis studies identified and validated E436 as a key amino acid ("hot spot") for the structural stability and function of the Leishmania infantum TryR (LiTryR) homodimer. The "proof of concept" was obtained when a small library of linear peptides representing rational variations of the α-helix spanning residues P435 to M447 was designed and tested. All of these peptides contained a Glu residue at position 2 (Glu 2 ) equivalent to the crucial E436 of Li-TryR. Unexpectedly, the linear PKIIQSVGIS-Nle-K-Nle 13-residue peptide 1, containing Lys 2 in place of Glu 2 , outperformed all other peptides in inhibiting both Li-TryR dimerization and oxidoreductase activity [10] . A rationale for these findings was provided by results from molecular dynamics (MD) simulations, which showed Lys 2 of the peptide can establish a strong electrostatic interaction with both D432 and E436 in the Li-TryR monomer it putatively binds to. Nonetheless, these peptide prototypes, despite their potency in inhibiting
TryR dimerization and enzymatic activity in vitro, were ineffective against L. infantum axenic amastigotes and promastigotes, most likely due to their inability to cross the cell membrane, as assessed by using FITC-labeled peptides [10] .
Short peptide sequences normally have negligible or random structure in water, whereas their binding targets usually recognize a specific conformation. The biological activity of peptide analogs can be improved by stabilizing their secondary structure and limiting their proteolysis through covalent cyclization [11] [12] [13] , most often by means of side chain-to-side chain linkage. In stabilizing -helices, the use of lactam bridges [14] [15] [16] and, more recently, short hydrocarbon chains [17] [18] [19] as staples has proven to be a successful approach to enhance helicity and to limit degradation by proteases of the resulting stapled peptides. In the case of hydrocarbon linkages, improvements in oral absorption [20] and cell permeability [21] [22] [23] have also been reported although these are two of the most significant yet poorly understood aspects of peptide stapling technology [24, 25] . So far, numerous examples of conformationally restricted peptides for several therapeutic targets have been reported to succesfully modulate PPIs [26] [27] [28] .
We recently reported [29] an example of helical content stabilization by preparing and testing a series of cyclic analogues of the most potent linear prototype TryR inhibitor 1 that were amide-bridged between amino acid side chains i and i+4. Our results indicated that several cyclic analogues retained potent inhibitory activity against the enzyme (when the staple was properly located) but also that their proteolytic stability against proteinase K was only modestly increased in comparison to those of their linear counterparts. Interestingly, we later demonstrated, for the first time to the best of our knowledge, in vitro activity against
Leishmania infantum of peptide-based inhibitors of TryR dimerization when they were conjugated to cationic cell-penetrating peptides (CPPs) [29] .
We herein report the synthesis of all-hydrocarbon stapled peptides 2 and 3 ( Figure 1 ), derived from the most potent linear prototype 1, which were designed as inhibitors of Li-TryR dimerization and activity with improved proteolytic stability over those of previous linear and lactam-bridged peptides. Their potential to penetrate cells and exert their leishmanicidal effects was also evaluated in vitro. Hydrocarbon cross-links were introduced between amino acid side-chains that are separated by one helical turn (i, i+4). The location of the hydrocarbon bridge at the non-recognition side was chosen on the basis of results obtained for the first series of lactam-bridged analogues, for which the best activities were found upon cyclization between positions 3/7 and 4/8 of the peptide sequence. Other possible cyclization positions resulted in a significant potency loss [29] . Thus, in line with these precedents, stapling positions 3/7 and 4/8, leading to hydrocarbon-stapled peptides 2 and 3, respectively, were selected. Fluorescein-labeled peptide conjugate 4 and the most proteolytically stable hydrocarbon-stapled peptide conjugated to a polyarginine CPP (5) (Figure 1 ) were also prepared for cellular uptake studies using fluorescence microscopy and in vitro evaluation of their antileishmanial activity. 
Results and Discussion

Chemical synthesis
The synthesis of the all-hydrocarbon stapled peptides was performed manually following standard solid-phase peptide synthesis (SPPS) protocols using a Rink amide MBHA polystyrene resin and N-Fmoc/ t Bu chemistry. The peptides were isolated acetylated at the Nterminus and as carboxamides at the C-terminal end. A low load resin (0.38 mmol/g) was used to minimize oligomer formation during the side-chain to side-chain cyclization. The preparation of hydrocarbon-stapled peptides 2 and 3 was carried out by introduction of two units of Fmoc-(S)--methyl--pentenylglycine at the suitable positions of the sequence in the elongation step as previously described by Verdine and co-workers (Scheme 1) [30, 31] .
Linear precursors 8 and 9 were prepared from the corresponding solid-supported linear peptides 6 and 7 after Fmoc-deprotection, acetylation and final cleavage from the resin.
Dicarba bridge formation was accomplished through on-resin ring-closing metathesis (RCM) using Grubb's second-generation ruthenium catalyst. Initial efforts to perform RCM at room temperature or prolonged heating at 90 °C for 12 h in a pressure tube using CH 2 Cl 2 as the solvent resulted in little to no conversion to the stapled peptide. However, when the mixture was heated under MW irradiation at 75 °C for 1 h, complete conversion was detected by HPLC-MS after cleavage of a small quantity of peptidyl-resin [32] . Next, the N-terminus of the peptides was acetylated, cleaved from the resin under standard conditions and purified by semi-preparative HPLC. Both E and Z isomers of 2 and 3 were detected by HPLC, which allowed the separation, isolation and subsequent biological evaluation of 2a and 2b. In the case of stapled peptide 3a only the major isomer could be isolated. E and Z isomers are generally distinguished by the value of the 3 Fluorescein-labeling of the most proteolytically stable 2a was achieved by linking the Nterminal group to FITC through a PEG linker (to increase aqueous solubility). To this end, standard sequences of Fmoc-deprotection and coupling with Fmoc-PEG-OH and FITC-NCS followed by TFA cleavage from the resin gave the desired compound 4 (Scheme 2).
Finally, to deliver the peptides into the parasites for leishmanicidal in vitro evaluation, the N-terminal end of 2a was covalently linked to a polyarginine (R 9 ) chain using standard SPPS methodology (compound 5, Scheme 2), as previously reported for our CPP-conjugates of linear peptide prototypes, lactam-bridged analogues and ,-peptide foldamers [10, 29, 33] .
All hydrocarbon-stapled peptides and linear precursors in this work were characterized by analytical HPLC and ESI-MS or MALDI-TOF after purification on a Biotage Isolera (linear analogues) or by semi-preparative HPLC (cyclic analogues) leading to the linear and cyclic peptides in low/moderate yields and high purity (>95%). 
CD studies and proteolytic stability
We used circular dichroism (CD) to determine the effect of the olefinic cross-link on the helical propensity of the peptides. The CD spectra were acquired in water in the presence of the secondary structure-promoting solvent 2,2,2-trifluoroethanol (TFE) (30% TFE/water) [34, 35] . TFE was selected as cosolvent due to the poor solubility of the linear hydrophobic peptide 1 in water. As expected, 2a and 3a showed the dual minima at 222 nm and 208 nm typical of -helices in contrast to the linear prototype 1, which exhibited a CD spectrum characteristic of an unstructured peptide ( Figure 2 ). The percentage of -helicity calculated for 2a and 3a, as calculated from the molar elipticity value at 222 nm and the number of amino acids using the equation of Baldwin and col. [36] , is 64 and 43%, respectively. Similar enhancements of helicity have been reported previously in related lactam-bridged peptide analogues [29] . We next compared the susceptibilities to degradation by proteinase K, a serine protease with broad substrate specificity, of the linear prototype 1 and the major isomers of hydrocarbon- [29] .
Biological activity Enzymatic assays
The effect of 2a and 3a and their linear precursors 8 and 9 on the activity and dimeric status of Li-TryR was evaluated (Table 1 ). Our results demonstrate that stapling modestly decreases the potency of the compounds as Li-TryR inhibitors relative to the linear peptide 1 and the corresponding 3,7-or 4,8-lactam-bridged analogues (Table 1) . In stark contrast, their activity as disruptors of Li-TryR dimerization is completely abolished and, surprisingly, some of them (analogues 2a, 3a and 9) even behave as stabilizers of the dimeric form of the enzyme, as demonstrated by the increased ELISA signal derived from the Li-TryR dimer after incubation with these compounds ( Figure S4 ). This stabilizing effect had not been previously observed and might be indicative of an unexpected interaction of the stapled peptides with Li-TryR that somehow impairs dimer disruption.
A deleterious effect on the disruptive activity of the peptides upon stapling was previously observed for analogues containing a Glu residue at position 2 (Glu 2 ) [32] . Thus, the present study reinforces our previous observations about the important nature of the covalent linker (lactam vs hydrocarbon) for TryR dimer destabilization and is in line with observations by others suggesting that the increase in overall hydrophobicity of the stapled peptide likely impacts not only the protein structure but also the interdomain water dynamics [37] because the water molecules present at the interface between protomers are likely to behave very differently depending on the polarity of the linker. The intriguing paradox is that inhibition of TryR activity appears to arise from either stabilization or destabilization of the homodimer. In both cases, the protein motions that presumably occur during the catalytic cycle are likely to be prevented or hampered due to binding of the peptide to one of the monomers. It is conceivable that the ensuing decrease in reduced trypanothione formation leads to the observed growth inhibition. Because of the functional and structural similarities between Li-TryR and human GR (H-GR), we compared the activity of peptides 2a and 3a against both enzymes under similar conditions. Surprisingly, both Li-TryR inhibitors activate, rather than inhibit, H-GR's oxidoreductase activity ( Figure 3) . 
In vitro antileishmanial activity
The all-hydrocarbon stapled analogues 2a and 3a and the linear precursors 8 and 9 were tested strategy already employed for the efficient uptake of the linear peptide prototype 1 and several lactam-bridged and mixed ,-peptide foldamer analogues [29, 33] . The R 9 sequence was also studied in parallel as a control. The EC 50 values obtained demonstrate that the leishmanicidal activity of 5 against axenic amastigotes and promastigotes is similar to that observed for the reference drugs edelfosine and miltefosine, as well as for the previously obtained linear and lactam cyclic peptide analogues. c Data from R 9 conjugates of linear peptide 1 (compound 12), the corresponding amide-bridged peptide conjugate 13 and the R 9 sequence 11 are taken from reference [29] for comparative purposes.
Conclusions
A series of all-hydrocarbon stapled peptides was designed with the aims of improving the proteolytic stability, enhancing the enzyme inhibition activity and increasing the cell permeability of previously reported linear peptide and lactam-bridged analogues that target the dimerization interface of Li-TryR. Although the new stapled peptides retain potent inhibitory activity against Li-TryR and are shown to be more resistant to proteolysis, they lose their ability to act as Li-TryR disruptors and appear to act as dimer stabilizers. The structural aspects involved in this unexpected and remarkable reversal in the mode of action await further elucidation. Attempts to co-crystallize Li-TryR with these stapled peptides for X-ray diffraction studies is currently underway as previous attempts of co-crystallization with linear or lactam-bridged analogues were hampered by the finding that the monomeric form of LiTryR precipitates.
The stapled peptides are not able to cross the cell membrane, as assessed by fluorescence experiments using an FITC-labeled peptide. Nonetheless, conjugation of the most proteolitically stable hydrocarbon-stapled peptide 2 to an R 9 CPP favors intracellular uptake and turns this compound into a molecule highly active against both promastigotic and axenic amastigotic forms of cultured L. infantum parasites. Therefore, we conclude that allhydrocarbon stapling of linear TryR dimerization peptide inhibitors does not significantly enhance cell permeability over that of alternatively cross-linked derivatives but has a major impact on their proteolytic stability as well as on their mode of interaction with the TryR homodimer.
EXPERIMENTAL
Chemistry
General Methods
Unless otherwise noted, analytical grade solvents and commercially available reagents were used without further purification. DIEA, piperidine, Ac 2 O and EDT were purchased from Aldrich (Germany), TFA from Fluka (Germany) and HCTU from Fluorochem (UK). Fmocprotected amino acids were purchased from Fluorochem (UK), Polypeptide (France), Novabiochem (Merck, Germany) and Iris Biotech (Germany). Fmoc-protected Rink Amide MBHA resin (0.56 mmol/g and 0.38 mmol/g loading) was purchased from Iris Biotech (Germany) and Novabiochem. All-hydrocarbon stapled peptides 2-5 and linear precursors 8 and 9 were synthesized manually on a 20-position cartridge manifold (Omega) in a 20-mL polypropylene syringe (Dulbecco) equipped with a porous polyethylene filter. The coupling reactions were carried out on solid phase using microwave radiation in a Biotage Initiator reactor in a 5 mL vial. Excluding the coupling reaction on the microwave reactor, the rest of the SPPS reactions were stirred using an IKA-100 orbital shaker.
After cleavage, the acidic crudes were sedimented in Et 2 O on a Hettich Universal 320R centrifuge at 5000 rpm. All the crude and samples were lyophilized using mixtures water/acetonitrile on a Telstar 6-80 instrument. The monitoring of the reactions was also performed by HPLC/MS through a HPLC-waters 12695 connected to a Waters Micromass ZQ spectrometer. The linear peptides were purified on a Biotage Isolera instrument using reverse phase columns (KP-C18-HS 12 g) and the cyclic peptides were purified on a semipreparative HPLC instrument. As the mobile phase, mixtures of A:B were used, where A = 0.05% TFA water and B = acetonitrile with a flow rate of 7 mL/min. The peptides were purified using a gradient from 0% of B to 100% of B in 30-45 min and were detected at 217 nm.
NMR spectra of cyclic peptides 2a, 2b and 3a were acquired using a Bruker AV-600 spectrometer, equipped with a cryoprobe, running at 600. 13 C ratio (0.25144953 [39] ). All the NMR spectra were analysed using the 
Solid-Phase Peptide Synthesis (SPPS)
Peptides were synthesized manually on resin following the standard Fmoc/tBu solid-phase orthogonal protection strategy. and DIEA (2.4 equiv.) in dry DMF (5 mL) was added. After sealing the vial, the reaction was heated in a microwave vial equipped with a magnetic stirrer for 10 minutes at 40 ºC. Then, the vial was opened, the supernatant removed and new coupling mixture added. This process was repeated 3 times in total (3 x 10 min) until complete coupling. Finally, the resin was transferred to a fritted syringe, drained and washed extensively (DMF/DCM/DMF/DCM, 5 x 0.5 min).
This protocol was repeated for the sequential anchoring of each amino acid. Coupling reactions to primary amines were monitored by the Kaiser ninhydrin test and to secondary amines by the Choranil test. In some cases, the progress of the reactions was also followed by analysis of a small sample of peptidylresin after acidic cleavage in an HPLC-MS instrument.
General acetylation procedure. After elongation of the peptides, the N-terminal group was acetylated in all the cases by DBU deprotection of the Fmoc-resin-bounded derivative as mentioned above followed by treatment of the deprotected resin with a mixture of The filtrates were precipitated over cold Et 2 O and centrifuged three times at 5000 rpm for 10 min. After removing the supernatant, the pellet was redissolved in water/acetonitrile and lyophilized. The crudes were purified to give the target peptides 2-5 in high purity. 2a,b) . After elongation of the peptide starting from 0.03 mmol of Rink amide resin, the metathesis reaction was carried out for 1 h following the general protocol under microwave conditions. Then, the cyclic peptide was N-acetylated and cleaved from the resin. The crude was purified by reverse phase chromatography using semipreparative HPLC to give the cyclic peptide 2a as major isomer (11.36 mg, 4% overall yield) and 2b as minor isomer (3.51 mg, 1% overall yield). Table S1 . Table S2 . Table S3 . (5) .
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The general elongation protocol was followed with 0.152 mmol of resin followed by acetylation and cleavage following the general protocol. After purification of the crude, 5 was isolated as a white lyophilized cotton-like solid (17.52 mg, 4% overall yield). Major isomer 5:
HPLC: t R = 7.52 min (G2-100, 15 min), >99% purity (at 214 nm). (9) . Following the general protocol for elongation with 0.038 mmol of resin, and after acetylation, cleavage and purification, linear precursor 9 was obtained as a white solid (2.5 mg, 5% overall yield). 
MALDI-TOF-MS
Circular dichroism (CD)
CD spectra were recorded in a Jasco J-815 spectropolarimeter (Tokyo, Japan) equipped with a
Peltier PTC-423S system. Stocks of known peptide concentration (ca. 0.5-1 mM) were prepared by weighing the lyophilized material. The spectra was acquired in water/30%TFE
solutions. TFE was chosen as cosolvent to increase the low water solubility of the peptides and because it is known that TFE stabilize pre-existing secondary structures in short lineal peptides [34, 35] . Similar conditions were used previously to determine the CD spectra of related lactambridged peptide analogues [29] . All measurements were carried out in triplicate at 25 °C and the cuvette path lengths were 0.1 cm for far UV region (250-195 nm). After subtracting appropriate reference spectra from the sample spectra, CD data were processed with the adaptative smoothing method of the Jasco SpectraAnalysis software. CD data are given in ellipticity units ([], deg.dmol.cm 2 .residue -1 ). The percentage of -helicity for 2a and 3a was calculated by the method described by Rohl and Baldwin [36] from the mean-residue ellipticity experimentally observed at 222 nm and the number of amino acids.
Protease susceptibility assays
Stock solutions of proteinase K were prepared in tris-buffered saline (TBS buffer) (50 μgmL -1 ) based on weight to volume). Stock solutions of the linear peptide 1 and hydrocarbon stapled peptides 2a and 3a (100 μM) were prepared using 10% DMSO in TBS buffer (pH 7.6, Aldrich). 
Li-TryR oxidoreductase activity
Oxidoreductase activity was determined according to the method described by Hamilton et al. °C in a VERSAmax microplate reader (Molecular Devices, California, USA). All the assays were conducted in triplicate in at least three independent experiments. Data were analyzed using a non-linear regression model with the Grafit6 software (Erithacus, Horley, Surrey, UK).
H-GR oxidoreductase activity
Reactions were carried out at 26 ºC (250 μL) in HEPES buffer pH 8.0 (40 mM) containing EDTA 1 mM), NADPH (300 μM), NADP + (60 μM), DTNB (100 μM), oxidized glutathione (GSSG, 1 μM), glycerol (0.02%), DMSO (1.5%) and recombinant H-GR (7 nM). The enzyme was pre-incubated with the peptides at 75 µM for 5 min prior to the addition of GSSG and NADPH. Enzyme activity was monitored by the increase in absorbance at 412 nm at 26 °C in a VERSAmax microplate reader (Molecular Devices, California, USA). All the assays were conducted in triplicate in three independent experiments.
Dimer quantitation assay
The stability of the Li-TryR dimeric form in the presence of stapled peptides 2 and 3 and linear precursors 8 and 9 was evaluated using the novel Enzyme-Linked ImmunoSorbent Assay (ELISA) recently developed in our laboratory [10] . Briefly a dual (HIS/FLAG) tagged Li-TryR 
Leishmanicidal activity and cytotoxicity assays.
Drug treatment of amastigotes was performed during the logarithmic growth phase at a concentration of 1×10 6 parasites/mL at 37 ºC for 24 h. Drug treatment of promastigotes was performed during the logarithmic growth phase at a concentration of 2×10 6 parasites/mL at 26 ºC for 24 h. Drug treatment of THP-1 cells was performed during the logarithmic growth phase at a concentration of 4×10 5 cells/mL at 37 ºC and 5% CO 2 for 24 h. LC 50 was evaluated by flow cytometry by the propidium iodide (PI) exclusion method [41] . After selection of the parasite population based on their forward scatter (FSC) and side scatter (SSC) values, live and dead parasite cells were identified by their permeability to PI. This is a conservative procedure that may underestimate EC 50 values as parasites that become fragmented as a result of cell death are excluded from the analysis. To minimize the presence of fragmented parasites drug treatment never exceeded 24 hours.
